$BIIB
BIOGEN INC.

2022 Q3 Form 10-Q Financial Statement

#000087504522000025 Filed on July 20, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2021 Q4
Revenue $2.509B $2.589B $2.734B
YoY Change -9.73% -6.7% -4.16%
Cost Of Revenue $469.5M $484.0M $660.1M
YoY Change -8.26% 5.29% 34.55%
Gross Profit $2.039B $2.105B $2.074B
YoY Change -10.06% -9.08% -12.2%
Gross Profit Margin 81.28% 81.31% 75.85%
Selling, General & Admin $563.3M $572.6M $787.9M
YoY Change -13.88% -10.15% -2.27%
% of Gross Profit 27.63% 27.2% 37.99%
Research & Development $549.2M $528.6M $699.5M
YoY Change -21.81% -9.66% -59.48%
% of Gross Profit 26.93% 25.11% 33.73%
Depreciation & Amortization $64.20M $67.20M $134.7M
YoY Change -1.38% 22.85% 49.0%
% of Gross Profit 3.15% 3.19% 6.5%
Operating Expenses $1.113B $1.101B $1.554B
YoY Change -17.99% -9.91% -38.54%
Operating Profit $926.5M $1.004B $519.8M
YoY Change 16.69% 106.69% -412.38%
Interest Expense $59.90M $65.80M -$113.2M
YoY Change -9.65% 16.67% -118.42%
% of Operating Profit 6.47% 6.55% -21.78%
Other Income/Expense, Net $1.700M -$26.20M -$1.600M
YoY Change -100.34% -127.18% -164.0%
Pretax Income $1.371B $1.270B $405.0M
YoY Change 371.01% 118.09% 14.76%
Income Tax $236.2M $216.7M $443.2M
% Of Pretax Income 17.23% 17.07% 109.43%
Net Earnings $1.135B $1.058B $368.2M
YoY Change 244.68% 135.9% 2.88%
Net Earnings / Revenue 45.23% 40.86% 13.47%
Basic Earnings Per Share $7.86 $7.25
Diluted Earnings Per Share $7.84 $7.24 $2.496M
COMMON SHARES
Basic Shares Outstanding 145.1M shares 145.9M shares 146.9M shares
Diluted Shares Outstanding 144.8M shares 146.2M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.911B $4.798B $3.803B
YoY Change 66.19% 57.27% 45.68%
Cash & Equivalents $3.676B $2.647B $2.261B
Short-Term Investments $1.236B $2.151B $1.541B
Other Short-Term Assets $1.496B $1.645B $740.8M
YoY Change 103.11% 114.26% -15.92%
Inventory $1.375B $1.294B $1.352B
Prepaid Expenses
Receivables $1.569B $1.568B $1.549B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $9.766B $9.741B $7.857B
YoY Change 36.35% 35.6% 14.08%
LONG-TERM ASSETS
Property, Plant & Equipment $3.266B $3.355B $3.416B
YoY Change -4.23% -2.53% 0.14%
Goodwill $5.741B $5.750B $5.761B
YoY Change -0.34% -0.25% -0.02%
Intangibles $2.009B $2.075B $2.221B
YoY Change -12.15% -12.99% -27.98%
Long-Term Investments $2.473B $2.604B $2.832B
YoY Change -17.21% -24.38% -22.87%
Other Assets $1.613B $1.501B $1.940B
YoY Change -20.11% -40.64% -33.1%
Total Long-Term Assets $15.09B $15.34B $16.02B
YoY Change -9.35% -11.26% -9.65%
TOTAL ASSETS
Total Short-Term Assets $9.766B $9.741B $7.857B
Total Long-Term Assets $15.09B $15.34B $16.02B
Total Assets $24.85B $25.08B $23.88B
YoY Change 4.4% 2.5% -3.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $383.2M $434.8M $589.2M
YoY Change -10.45% 15.85% 29.52%
Accrued Expenses $1.377B $1.344B $1.471B
YoY Change -9.46% -11.88% -14.28%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $999.8M $999.1M
YoY Change -100.0%
Total Short-Term Liabilities $3.926B $5.018B $4.298B
YoY Change -6.77% 49.92% 14.86%
LONG-TERM LIABILITIES
Long-Term Debt $6.279B $6.277B $6.274B
YoY Change 0.11% -13.64% -15.51%
Other Long-Term Liabilities $1.198B $1.168B $1.321B
YoY Change -9.11% -13.9% -0.68%
Total Long-Term Liabilities $1.198B $1.168B $1.321B
YoY Change -9.11% -13.9% -0.68%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.926B $5.018B $4.298B
Total Long-Term Liabilities $1.198B $1.168B $1.321B
Total Liabilities $12.09B $13.22B $12.92B
YoY Change -6.48% -0.28% -7.29%
SHAREHOLDERS EQUITY
Retained Earnings $15.92B $14.96B $13.91B
YoY Change 17.52% 7.62% -0.46%
Common Stock $100.0K $100.0K $100.0K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.977B $2.977B $2.977B
YoY Change 0.0% 0.0% 0.0%
Treasury Stock Shares 23.80M shares
Shareholders Equity $12.78B $11.87B $10.90B
YoY Change
Total Liabilities & Shareholders Equity $24.85B $25.08B $23.88B
YoY Change 4.4% 2.5% -3.01%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2021 Q4
OPERATING ACTIVITIES
Net Income $1.135B $1.058B $368.2M
YoY Change 244.68% 135.9% 2.88%
Depreciation, Depletion And Amortization $64.20M $67.20M $134.7M
YoY Change -1.38% 22.85% 49.0%
Cash From Operating Activities $661.0M $736.5M $838.3M
YoY Change -17.92% -39.99% -328.36%
INVESTING ACTIVITIES
Capital Expenditures -$59.10M -$38.80M -$68.50M
YoY Change -4.52% -46.04% -32.18%
Acquisitions
YoY Change
Other Investing Activities $1.731B $732.3M -$44.20M
YoY Change -1108.33% -1006.31% -32.42%
Cash From Investing Activities $1.672B $693.5M -$112.7M
YoY Change -815.84% -554.16% -32.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.252B -471.5M 9.800M
YoY Change 67.7% -16.47% -102.44%
NET CHANGE
Cash From Operating Activities 661.0M 736.5M 838.3M
Cash From Investing Activities 1.672B 693.5M -112.7M
Cash From Financing Activities -1.252B -471.5M 9.800M
Net Change In Cash 1.081B 958.5M 735.4M
YoY Change -718.59% 87.9% -178.69%
FREE CASH FLOW
Cash From Operating Activities $661.0M $736.5M $838.3M
Capital Expenditures -$59.10M -$38.80M -$68.50M
Free Cash Flow $720.1M $775.3M $906.8M
YoY Change -16.96% -40.32% -440.77%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000875045
dei City Area Code
CityAreaCode
617
dei Local Phone Number
LocalPhoneNumber
679-2000
dei Entity File Number
EntityFileNumber
0-19311
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
dei Amendment Flag
AmendmentFlag
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
145113047 shares
CY2022Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
BIOGEN INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0112644
dei Entity Address Address Line1
EntityAddressAddressLine1
225 Binney Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Cambridge
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02142
dei Security12b Title
Security12bTitle
Common Stock, $0.0005 par value
dei Trading Symbol
TradingSymbol
BIIB
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
145113047 shares
CY2022Q2 us-gaap Revenues
Revenues
2589100000 usd
CY2021Q2 us-gaap Revenues
Revenues
2775000000 usd
us-gaap Revenues
Revenues
5120900000 usd
us-gaap Revenues
Revenues
5469000000 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
484000000.0 usd
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
459700000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1237900000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
937800000 usd
CY2022Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
528600000 usd
CY2021Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
585100000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1080300000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1099300000 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
572600000 usd
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
637300000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1207500000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1232300000 usd
CY2022Q2 biib Amortization And Impairment Of Acquired Intangible Assets
AmortizationAndImpairmentOfAcquiredIntangibleAssets
67500000 usd
CY2021Q2 biib Amortization And Impairment Of Acquired Intangible Assets
AmortizationAndImpairmentOfAcquiredIntangibleAssets
604100000 usd
biib Amortization And Impairment Of Acquired Intangible Assets
AmortizationAndImpairmentOfAcquiredIntangibleAssets
134400000 usd
biib Amortization And Impairment Of Acquired Intangible Assets
AmortizationAndImpairmentOfAcquiredIntangibleAssets
702200000 usd
CY2022Q2 biib Collaborationprofitlosssharing
Collaborationprofitlosssharing
29400000 usd
CY2021Q2 biib Collaborationprofitlosssharing
Collaborationprofitlosssharing
-15200000 usd
biib Collaborationprofitlosssharing
Collaborationprofitlosssharing
-87900000 usd
biib Collaborationprofitlosssharing
Collaborationprofitlosssharing
53300000 usd
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
4500000 usd
CY2021Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-300000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
11600000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
33500000 usd
CY2022Q2 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 usd
CY2021Q2 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
18000000.0 usd
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 usd
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
18000000.0 usd
CY2022Q2 us-gaap Restructuring Charges
RestructuringCharges
70600000 usd
CY2021Q2 us-gaap Restructuring Charges
RestructuringCharges
0 usd
us-gaap Restructuring Charges
RestructuringCharges
108700000 usd
us-gaap Restructuring Charges
RestructuringCharges
0 usd
CY2022Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
428600000 usd
CY2021Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
96400000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
165300000 usd
biib Income Loss From Equity Method Investments Net Of Tax
IncomeLossFromEquityMethodInvestmentsNetOfTax
16100000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
1058700000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-410500000 usd
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
1319600000 usd
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
2192900000 usd
us-gaap Costs And Expenses
CostsAndExpenses
3504000000 usd
us-gaap Costs And Expenses
CostsAndExpenses
4419900000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1269500000 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
582100000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1616900000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1049100000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
216700000 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-409100000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
342300000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-364900000 usd
CY2022Q2 biib Income Loss From Equity Method Investments Net Of Tax
IncomeLossFromEquityMethodInvestmentsNetOfTax
5900000 usd
CY2021Q2 biib Income Loss From Equity Method Investments Net Of Tax
IncomeLossFromEquityMethodInvestmentsNetOfTax
34300000 usd
biib Income Loss From Equity Method Investments Net Of Tax
IncomeLossFromEquityMethodInvestmentsNetOfTax
2600000 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
1025500000 usd
us-gaap Profit Loss
ProfitLoss
1277200000 usd
us-gaap Profit Loss
ProfitLoss
1430100000 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
700000 usd
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
577000000.0 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-84600000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
571400000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
1058000000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
448500000 usd
us-gaap Net Income Loss
NetIncomeLoss
1361800000 usd
us-gaap Net Income Loss
NetIncomeLoss
858700000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.25
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
9.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.70
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.24
CY2021Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-500000 usd
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.99
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
9.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.68
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145900000 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
149700000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
146500000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
150800000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
146200000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
150100000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
146800000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
151200000 shares
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
1058000000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
448500000 usd
us-gaap Net Income Loss
NetIncomeLoss
1361800000 usd
us-gaap Net Income Loss
NetIncomeLoss
858700000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-8300000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-84600000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-18000000.0 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-1300000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
57200000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-11000000.0 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
73100000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
138600000 usd
CY2022Q2 us-gaap Translation Adjustment For Net Investment Hedge Net Of Tax Period Increase Decrease
TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease
-31700000 usd
CY2021Q2 us-gaap Translation Adjustment For Net Investment Hedge Net Of Tax Period Increase Decrease
TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease
-2300000 usd
us-gaap Translation Adjustment For Net Investment Hedge Net Of Tax Period Increase Decrease
TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease
-25500000 usd
us-gaap Translation Adjustment For Net Investment Hedge Net Of Tax Period Increase Decrease
TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease
20100000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-1800000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-400000 usd
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-2700000 usd
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-2400000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
572000000.0 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-14200000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
15900000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-36000000.0 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-32600000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
4800000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2500000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3700000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
127200000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1062800000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
451000000.0 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1358100000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
985900000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
700000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
576900000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1063500000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1027900000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1273500000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1557900000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2646600000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2261400000 usd
CY2022Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
2151300000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
1541100000 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1567600000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1549400000 usd
CY2022Q2 biib Duefromanti Cd20therapeuticprograms
DuefromantiCD20therapeuticprograms
435900000 usd
CY2021Q4 biib Duefromanti Cd20therapeuticprograms
DuefromantiCD20therapeuticprograms
412300000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
1294200000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
1351500000 usd
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1645300000 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
740800000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
9740900000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
7856500000 usd
CY2022Q2 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
1102900000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
892000000.0 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3355100000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3416400000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
321100000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
375400000 usd
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2075300000 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2221300000 usd
CY2022Q2 us-gaap Goodwill
Goodwill
5749600000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
5761100000 usd
CY2022Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1235700000 usd
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1415100000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1500800000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1939500000 usd
CY2022Q2 us-gaap Assets
Assets
25081400000 usd
CY2021Q4 us-gaap Assets
Assets
23877300000 usd
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
174700000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
434800000 usd
CY2022Q2 us-gaap Notes Payable Current
NotesPayableCurrent
999800000 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
999100000 usd
CY2022Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
284900000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
589200000 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3298500000 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2535200000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5018000000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4298200000 usd
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
6277400000 usd
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
6274000000 usd
CY2022Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
480600000 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
694500000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
274200000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
330400000 usd
CY2022Q2 us-gaap Treasury Stock Value
TreasuryStockValue
2977100000 usd
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1167800000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1320500000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
13218000000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
12917600000 usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
100000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
100000 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
68200000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-110400000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-106700000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
14959900000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
13911700000 usd
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2977100000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
11872500000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10896200000 usd
CY2022Q2 us-gaap Minority Interest
MinorityInterest
-9100000 usd
CY2021Q4 us-gaap Minority Interest
MinorityInterest
63500000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11863400000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10959700000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25081400000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23877300000 usd
us-gaap Profit Loss
ProfitLoss
1277200000 usd
us-gaap Profit Loss
ProfitLoss
1430100000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
277900000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
219800000 usd
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 usd
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
585900000 usd
us-gaap Inventory Write Down
InventoryWriteDown
305600000 usd
us-gaap Inventory Write Down
InventoryWriteDown
8300000 usd
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 usd
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
18000000.0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
123300000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
124100000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
11600000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
33500000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-47500000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-622800000 usd
us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
-269300000 usd
us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
-283600000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2600000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
16100000 usd
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
1505400000 usd
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-112200000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-104100000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
67300000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-211500000 usd
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
23600000 usd
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
8700000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
243300000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
193800000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
634000000.0 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-188400000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-65900000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
171500000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
134000000.0 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
97300000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
898300000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1996300000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
94800000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
164500000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1461500000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1452700000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
2311600000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
1626900000 usd
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
990300000 usd
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
0 usd
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 usd
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
28100000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1900000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 usd
us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
0 usd
us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
91200000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-2000000.0 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-2000000.0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
45500000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-217400000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
500000000.0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1050000000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
11500000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
14200000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
170000000.0 usd
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
12100000 usd
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
-94800000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
11400000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-20500000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-488000000.0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1349500000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
455800000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
429400000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-70600000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-18600000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2261400000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1331200000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2646600000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1742000000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11220700000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
1058700000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4800000 usd
CY2022Q2 biib Noncontrolling Interest Capital Contribution
NoncontrollingInterestCapitalContribution
11800000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
10000000.0 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-700000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-58000000.0 usd
CY2022Q2 us-gaap Stockholders Equity Other
StockholdersEquityOther
-100000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11863400000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10959700000 usd
us-gaap Profit Loss
ProfitLoss
1277200000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3700000 usd
biib Noncontrolling Interest Capital Contribution
NoncontrollingInterestCapitalContribution
12000000.0 usd
us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
28900000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-40400000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-128400000 usd
us-gaap Stockholders Equity Other
StockholdersEquityOther
-1300000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11863400000 usd
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10663200000 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
1025500000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2400000 usd
CY2021Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
100000000.0 usd
CY2021Q2 biib Noncontrolling Interest Capital Contribution
NoncontrollingInterestCapitalContribution
5000000.0 usd
CY2021Q2 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
13700000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-800000 usd
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-55800000 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11214800000 usd
biib Noncontrolling Interest Capital Contribution
NoncontrollingInterestCapitalContribution
5100000 usd
us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
33400000 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10686100000 usd
us-gaap Profit Loss
ProfitLoss
1430100000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
127800000 usd
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
100000000.0 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-47600000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-128400000 usd
us-gaap Stockholders Equity Other
StockholdersEquityOther
-1500000 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11214800000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
10400000 usd
biib Interest In Subsidiary
InterestInSubsidiary
1.000
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of our condensed consolidated financial statements requires us to make estimates, judgments and assumptions that may affect the reported amounts of assets, liabilities, equity, revenue and expense and related disclosure of contingent assets and liabilities. On an ongoing basis we evaluate our estimates, judgments and assumptions. We base our estimates on historical experience and on various other assumptions that we believe are reasonable, the results of which form the basis for making judgments about the carrying values of assets, liabilities and equity and the amount of revenue and expense. Actual results may differ from these estimates.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The length of time and full extent to which the COVID-19 pandemic directly or indirectly impacts our business, results of operations and financial condition, including sales, expense, reserves and allowances, the supply chain, manufacturing, clinical trials, research and development costs and employee-related costs, depends on future developments that are highly uncertain, subject to change and are difficult to predict, including as a result of new information that may emerge concerning COVID-19 and the actions taken to contain or treat COVID-19 as well as the economic impact on local, regional, national and international customers and markets. Additionally, the ongoing geopolitical tensions related to the conflict in Ukraine, and the related sanctions and other penalties imposed, are creating substantial uncertainty in the global economy. The extent and duration of the conflict, sanctions and resulting market disruptions are highly unpredictable. We have made estimates of the impact of the COVID-19 pandemic and the ongoing geopolitical conflict within our condensed consolidated financial statements and there may be changes to those estimates in future periods.</span></div>
CY2022Q2 biib Number Of Wholesalers
NumberOfWholesalers
2 wholesaler
biib Number Of Wholesalers
NumberOfWholesalers
2 wholesaler
CY2022Q2 us-gaap Restructuring Charges
RestructuringCharges
70600000 usd
us-gaap Restructuring Charges
RestructuringCharges
108700000 usd
CY2022Q2 us-gaap Severance Costs1
SeveranceCosts1
60900000 usd
us-gaap Severance Costs1
SeveranceCosts1
88600000 usd
CY2022Q2 us-gaap Other Restructuring Costs
OtherRestructuringCosts
9700000 usd
us-gaap Other Restructuring Costs
OtherRestructuringCosts
9700000 usd
CY2022Q2 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
-500000 usd
biib Number Of Wholesalers
NumberOfWholesalers
2 wholesaler
CY2022Q2 biib Number Of Wholesalers
NumberOfWholesalers
2 wholesaler
CY2021Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
935300000 usd
biib Current Provisions To Product Revenue Reserves Relating To Sales In Current Year
CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear
1690200000 usd
biib Adjustments To Product Revenue Reserves Relating To Sales In Prior Years
AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears
64300000 usd
biib Payments Returns Applied Against Product Revenue Reserves Relating To Current Year
PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear
1077100000 usd
biib Payments Returns Applied Against Product Revenue Reserves Relating To Prior Year
PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear
500300000 usd
CY2022Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
983800000 usd
CY2022Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
983800000 usd
CY2021Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
935300000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
195000000.0 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
180000000.0 usd
CY2022Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
378000000.0 usd
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
349600000 usd
CY2022Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
706300000 usd
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
814000000.0 usd
CY2022Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
209900000 usd
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
187900000 usd
CY2022Q2 biib Inventorynetcurrentandnoncurrent
Inventorynetcurrentandnoncurrent
1294200000 usd
CY2021Q4 biib Inventorynetcurrentandnoncurrent
Inventorynetcurrentandnoncurrent
1351500000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
130000000.0 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
210000000.0 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
195000000.0 usd
CY2022Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
7598200000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5522900000 usd
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2075300000 usd
CY2021Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
7609800000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5388500000 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2221300000 usd
CY2022Q2 biib Amortization And Impairment Of Acquired Intangible Assets
AmortizationAndImpairmentOfAcquiredIntangibleAssets
67500000 usd
biib Amortization And Impairment Of Acquired Intangible Assets
AmortizationAndImpairmentOfAcquiredIntangibleAssets
134400000 usd
CY2021Q2 biib Amortization And Impairment Of Acquired Intangible Assets
AmortizationAndImpairmentOfAcquiredIntangibleAssets
604100000 usd
biib Amortization And Impairment Of Acquired Intangible Assets
AmortizationAndImpairmentOfAcquiredIntangibleAssets
702200000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
165000000.0 usd
CY2021Q4 us-gaap Goodwill
Goodwill
5761100000 usd
us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
-11500000 usd
CY2022Q2 us-gaap Goodwill
Goodwill
5749600000 usd
CY2022Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0 usd
CY2022Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
biib Technological And Regulatory Success Probability
TechnologicalAndRegulatorySuccessProbability
0.109
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3200000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2433100000 usd
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
4500000 usd
CY2021Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-300000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
11600000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
33500000 usd
CY2022Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
197500000 usd
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
209100000 usd
CY2022Q2 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
6546700000 usd
CY2022Q2 us-gaap Notes Payable
NotesPayable
7277200000 usd
CY2021Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
8004700000 usd
CY2021Q4 us-gaap Notes Payable
NotesPayable
7273100000 usd
CY2021Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
1167000000 usd
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
2144900000 usd
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
1632200000 usd
CY2022Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
3279600000 usd
CY2022Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
400000 usd
CY2022Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
25800000 usd
CY2022Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3254200000 usd
CY2022Q2 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
1137200000 usd
CY2022Q2 biib Equity Securities Available For Sale Accumulated Gross Unrealized Gain Before Tax
EquitySecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2022Q2 biib Equity Securities Available For Sale Accumulated Gross Unrealized Loss Before Tax
EquitySecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax
351600000 usd
CY2022Q2 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
785600000 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
2435900000 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
400000 usd
CY2021Q4 biib Equity Securities Available For Sale Accumulated Gross Unrealized Gain Before Tax
EquitySecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax
160900000 usd
CY2021Q4 biib Equity Securities Available For Sale Accumulated Gross Unrealized Loss Before Tax
EquitySecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax
279400000 usd
CY2021Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
1048500000 usd
CY2022Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
2151300000 usd
CY2022Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
2135600000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
1541100000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1541700000 usd
CY2022Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
1089400000 usd
CY2022Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
1130100000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
868200000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
870200000 usd
CY2022Q2 biib Available For Sale Securities Debt Maturities After Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost
13500000 usd
CY2022Q2 biib Available For Sale Securities Debt Maturities After Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue
13900000 usd
CY2021Q4 biib Available For Sale Securities Debt Maturities After Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost
23800000 usd
CY2021Q4 biib Available For Sale Securities Debt Maturities After Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue
24000000.0 usd
CY2022Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3254200000 usd
CY2022Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
3279600000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2433100000 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
2435900000 usd
biib Average Maturity Of Marketable Securities
AverageMaturityOfMarketableSecurities
P11M
CY2021 biib Average Maturity Of Marketable Securities
AverageMaturityOfMarketableSecurities
P10M
CY2022Q2 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
917900000 usd
CY2021Q2 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
633500000 usd
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1461500000 usd
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1452700000 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
0 usd
CY2021Q2 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
100000 usd
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
0 usd
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
300000 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
-800000 usd
CY2021Q2 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
-500000 usd
us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
-1400000 usd
us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
-1200000 usd
CY2022Q2 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
37100000 usd
us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
49300000 usd
CY2021Q2 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
4800000 usd
us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-12600000 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2131000000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2006600000 usd
CY2022Q2 us-gaap Depreciation
Depreciation
67200000 usd
us-gaap Depreciation
Depreciation
143500000 usd
CY2021Q2 us-gaap Depreciation
Depreciation
54700000 usd
us-gaap Depreciation
Depreciation
103500000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-110400000 usd
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-299000000.0 usd
CY2015Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1000000000 usd
CY2022Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.03625
CY2022Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.03625
CY2022Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.03625
CY2022Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.03625
CY2022Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.03625
CY2022Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.03625
CY2021Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
151800000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-106700000 usd
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
30800000 usd
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-34500000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3700000 usd
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
78200000 usd
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
49000000.0 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
127200000 usd
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-171800000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
1058000000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
448500000 usd
us-gaap Net Income Loss
NetIncomeLoss
1361800000 usd
us-gaap Net Income Loss
NetIncomeLoss
858700000 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145900000 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
149700000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
146500000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
150800000 shares
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
300000 shares
CY2021Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
400000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
300000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
400000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
146200000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
150100000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
146800000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
151200000 shares
CY2022Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
59100000 usd
CY2021Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
59400000 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
130900000 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
137900000 usd
CY2022Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
2300000 usd
CY2021Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1700000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
5100000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
4300000 usd
CY2022Q2 biib Share Based Compensation Expense Included In Costs And Expenses
ShareBasedCompensationExpenseIncludedInCostsAndExpenses
56800000 usd
CY2021Q2 biib Share Based Compensation Expense Included In Costs And Expenses
ShareBasedCompensationExpenseIncludedInCostsAndExpenses
57700000 usd
biib Share Based Compensation Expense Included In Costs And Expenses
ShareBasedCompensationExpenseIncludedInCostsAndExpenses
125800000 usd
biib Share Based Compensation Expense Included In Costs And Expenses
ShareBasedCompensationExpenseIncludedInCostsAndExpenses
133600000 usd
CY2022Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
10200000 usd
CY2021Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
10900000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
23000000.0 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
24900000 usd
biib Share Based Compensation Expense Included In Costs And Expenses
ShareBasedCompensationExpenseIncludedInCostsAndExpenses
133600000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
59100000 usd
CY2021Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
59400000 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
130900000 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
137900000 usd
CY2022Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
2300000 usd
CY2021Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1700000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
5100000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
4300000 usd
CY2022Q2 biib Share Based Compensation Expense Included In Costs And Expenses
ShareBasedCompensationExpenseIncludedInCostsAndExpenses
56800000 usd
CY2021Q2 biib Share Based Compensation Expense Included In Costs And Expenses
ShareBasedCompensationExpenseIncludedInCostsAndExpenses
57700000 usd
biib Share Based Compensation Expense Included In Costs And Expenses
ShareBasedCompensationExpenseIncludedInCostsAndExpenses
125800000 usd
CY2022Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022Q2 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.006
CY2021Q2 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.013
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.004
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.011
CY2022Q2 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.038
CY2021Q2 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.077
us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.053
us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.091
CY2022Q2 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.014
CY2021Q2 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.029
us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.016
us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.033
CY2022Q2 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization
0.001
CY2021Q2 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization
-0.008
us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization
0.002
us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization
-0.001
CY2022Q2 biib Effective Tax Rate Reconciliation Gilt Itax
EffectiveTaxRateReconciliationGILTItax
0.002
CY2021Q2 biib Effective Tax Rate Reconciliation Gilt Itax
EffectiveTaxRateReconciliationGILTItax
0.015
biib Effective Tax Rate Reconciliation Gilt Itax
EffectiveTaxRateReconciliationGILTItax
0.002
biib Effective Tax Rate Reconciliation Gilt Itax
EffectiveTaxRateReconciliationGILTItax
0.013
CY2022Q2 biib Effective Tax Rate Reconciliation Sale Of Samsung Bioepis
EffectiveTaxRateReconciliationSaleOfSamsungBioepis
-0.037
CY2021Q2 biib Effective Tax Rate Reconciliation Sale Of Samsung Bioepis
EffectiveTaxRateReconciliationSaleOfSamsungBioepis
0
biib Effective Tax Rate Reconciliation Sale Of Samsung Bioepis
EffectiveTaxRateReconciliationSaleOfSamsungBioepis
-0.029
biib Effective Tax Rate Reconciliation Sale Of Samsung Bioepis
EffectiveTaxRateReconciliationSaleOfSamsungBioepis
0
CY2022Q2 biib Effective Tax Rate Reconciliation Litigation Agreement
EffectiveTaxRateReconciliationLitigationAgreement
0.085
CY2021Q2 biib Effective Tax Rate Reconciliation Litigation Agreement
EffectiveTaxRateReconciliationLitigationAgreement
0
biib Effective Tax Rate Reconciliation Litigation Agreement
EffectiveTaxRateReconciliationLitigationAgreement
0.067
biib Effective Tax Rate Reconciliation Litigation Agreement
EffectiveTaxRateReconciliationLitigationAgreement
0
CY2022Q2 biib Effective Tax Rate Reconciliation Nuer Immune Tax Impacts
EffectiveTaxRateReconciliationNuerImmuneTaxImpacts
0
CY2021Q2 biib Effective Tax Rate Reconciliation Nuer Immune Tax Impacts
EffectiveTaxRateReconciliationNuerImmuneTaxImpacts
-0.831
biib Effective Tax Rate Reconciliation Nuer Immune Tax Impacts
EffectiveTaxRateReconciliationNuerImmuneTaxImpacts
0.052
biib Effective Tax Rate Reconciliation Nuer Immune Tax Impacts
EffectiveTaxRateReconciliationNuerImmuneTaxImpacts
-0.463
CY2022Q2 biib Effective Tax Rate Reconciliation International Reorganization
EffectiveTaxRateReconciliationInternationalReorganization
-0.040
CY2021Q2 biib Effective Tax Rate Reconciliation International Reorganization
EffectiveTaxRateReconciliationInternationalReorganization
0
biib Effective Tax Rate Reconciliation International Reorganization
EffectiveTaxRateReconciliationInternationalReorganization
-0.031
biib Effective Tax Rate Reconciliation International Reorganization
EffectiveTaxRateReconciliationInternationalReorganization
0
CY2022Q2 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.004
CY2021Q2 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.004
us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.004
us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.006
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.171
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.703
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.212
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.348
CY2021Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
490000000 usd
CY2021Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
490000000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
390000000 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
85000000 usd
CY2022Q2 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
1505400000 usd
CY2021Q2 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
0 usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
1505400000 usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
0 usd
CY2022Q2 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
900000000.0 usd
CY2021Q2 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 usd
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
900000000.0 usd
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 usd
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
12600000 usd
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
2700000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
15500000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
5600000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
65800000 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
56400000 usd
us-gaap Interest Expense
InterestExpense
131900000 usd
us-gaap Interest Expense
InterestExpense
121100000 usd
CY2022Q2 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-78200000 usd
CY2021Q2 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
153900000 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-269300000 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-282700000 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-19200000 usd
CY2021Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-800000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-27500000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-9400000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-26200000 usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000000.0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-26900000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2900000 usd
CY2022Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
428600000 usd
CY2021Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
96400000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
165300000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-410500000 usd
CY2022Q2 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
900000000 usd
CY2022Q2 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-77200000 usd
CY2021Q2 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
154300000 usd
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-267900000 usd
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-281800000 usd
CY2022Q2 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-700000 usd
CY2021Q2 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
400000 usd
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-500000 usd
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
6600000 usd
CY2022Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-76500000 usd
CY2021Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
153900000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-267400000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-288400000 usd
CY2022Q2 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
900000000.0 usd
CY2021Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
0 usd
CY2022Q2 biib Collaborationexpensesaccrual
Collaborationexpensesaccrual
261800000 usd
CY2021Q4 biib Collaborationexpensesaccrual
Collaborationexpensesaccrual
324700000 usd
CY2022Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
216200000 usd
CY2021Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
234700000 usd
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
281500000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
345100000 usd
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
793000000.0 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
828600000 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3298500000 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2535200000 usd
CY2022Q2 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
900000000 usd
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1167800000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1320500000 usd
CY2022Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
499600000 usd
CY2021Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
664500000 usd
CY2022Q2 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
900000000 usd
CY2022Q2 us-gaap Severance Costs1
SeveranceCosts1
60900000 usd
us-gaap Severance Costs1
SeveranceCosts1
88600000 usd
us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
10400000 usd
CY2021Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
490000000 usd
CY2021Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
490000000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
390000000 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
85000000 usd
CY2022Q2 biib Investment In Biotechnology Companies That Are Determined To Be Unconsolidated Variable Interest Entities
InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities
23500000 usd
CY2021Q4 biib Investment In Biotechnology Companies That Are Determined To Be Unconsolidated Variable Interest Entities
InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities
24600000 usd
CY2020Q4 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
200000000 usd
CY2022Q2 us-gaap Restructuring Charges
RestructuringCharges
70600000 usd
us-gaap Restructuring Charges
RestructuringCharges
108700000 usd
CY2022Q2 us-gaap Other Restructuring Costs
OtherRestructuringCosts
9700000 usd
us-gaap Other Restructuring Costs
OtherRestructuringCosts
9700000 usd
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
990300000 usd

Files In Submission

Name View Source Status
0000875045-22-000025-index-headers.html Edgar Link pending
0000875045-22-000025-index.html Edgar Link pending
0000875045-22-000025.txt Edgar Link pending
0000875045-22-000025-xbrl.zip Edgar Link pending
biib-20220630.htm Edgar Link pending
biib-20220630.xsd Edgar Link pending
biib-20220630_cal.xml Edgar Link unprocessable
biib-20220630_def.xml Edgar Link unprocessable
biib-20220630_g1.jpg Edgar Link pending
biib-20220630_g10.jpg Edgar Link pending
biib-20220630_g11.jpg Edgar Link pending
biib-20220630_g12.jpg Edgar Link pending
biib-20220630_g13.jpg Edgar Link pending
biib-20220630_g14.jpg Edgar Link pending
biib-20220630_g15.jpg Edgar Link pending
biib-20220630_g16.jpg Edgar Link pending
biib-20220630_g17.jpg Edgar Link pending
biib-20220630_g18.jpg Edgar Link pending
biib-20220630_g19.jpg Edgar Link pending
biib-20220630_g2.jpg Edgar Link pending
biib-20220630_g20.jpg Edgar Link pending
biib-20220630_g21.jpg Edgar Link pending
biib-20220630_g22.jpg Edgar Link pending
biib-20220630_g3.jpg Edgar Link pending
biib-20220630_g4.jpg Edgar Link pending
biib-20220630_g5.jpg Edgar Link pending
biib-20220630_g6.jpg Edgar Link pending
biib-20220630_g7.jpg Edgar Link pending
biib-20220630_g8.jpg Edgar Link pending
biib-20220630_g9.jpg Edgar Link pending
biib-20220630_htm.xml Edgar Link completed
biib-20220630_lab.xml Edgar Link unprocessable
biib-20220630_pre.xml Edgar Link unprocessable
biib-2022630xex311.htm Edgar Link pending
biib-2022630xex312.htm Edgar Link pending
biib-2022630xex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending